维立志博-B于Jefferies全球医疗健康大会发布维利信最新临床及安全性数据

财中社
Nov 20

11月20日,维立志博-B(09887)发布公告,宣布公司创始人、董事长兼首席执行官康小强博士于2026年11月19日出席2026 Jefferies全球医疗健康大会,发表了关于公司自主研发的维利信®(奥帕替苏米单抗,抗PD-L1/4-1BB双特异性抗体)的最新临床及安全性数据。  维利信®在多个适应症中展现出显著的长期生存获益,尤其是在肺外神经内分泌癌(EP-NEC)中,其中位OS为8.7个月,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10